Bisphosphonate(Zoledronic acid)와 연관된 하악골의 골수염-증례보고
Bisphosphonate(zoledronic acid) related osteomyelitis on mandible: a case report.
이수연, 최소영, 김진욱, 권태건, 장현중, 김진수, 이상한,
소속 상세정보
이수연 ( Lee Su-Youn ) - 경북대학교 치과대학 구강악안면외과학교실
최소영 ( Choi So-Young ) - 경북대학교 치과대학 구강악안면외과학교실
김진욱 ( Kim Jin-Wook ) - 경북대학교 치과대학 구강악안면외과학교실
권태건 ( Kwon Tae-Geon ) - 경북대학교 치과대학 구강악안면외과학교실
장현중 ( Jang Hyun-Jung ) - 경북대학교 치과대학 구강악안면외과학교실
김진수 ( Kim Chin-Soo ) - 경북대학교 치과대학 구강악안면외과학교실
이상한 ( Lee Sang-Han ) - 경북대학교 치과대학 구강악안면외과학교실
KMID : 0360120080300040395
Abstract
Bisphosphonate are a class of drugs with a chemical structure which inhibit bone resorption, actually used for metastatic bone disease, osteoporosis, Paget’s disease and multiple myeloma. Significant complication associated with their use is reported recently : mandibular and maxillary osteomyelitis or osteonecrosis. So we here report our case about the patient who was diagnosed of prostate cancer in 2004 April and treated with bisphosphonate(Zoledronic acid-Zometa(R), Novartis Co.) intravenously every 3 to 4weeks at a dose of 4mg to prevent bone metastasis, and also, the patient who came to the hospital due to the bony exposure of mandible and pain in 2006 November and was diagnosed osteomyelitis of mandible as a result of biopsy, bone scan, PET CT examination.
키워드
Bisphosphonate;Mandibular osteomyelitis;Prostate cancer;Metastatic bone disease
원문 및 링크아웃 정보
등재저널 정보